Gain Therapeutics stock price
게인 테라퓨틱스NASDAQ:GANX · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Gain Therapeutics last closed at $1.71 (-0.58%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -3.6×. Its overall grade ranks 481 of 739 stocks in Healthcare.
About this company
Gain Therapeutics last closed at $1.71 (-0.58%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 481/739
Valuation grade B
Related stocks
- RocheCustomer
Gain Therapeutics의 알츠하이머/파킨슨 등 신약 후보가 향후 기술이전·공동개발로 연결될 수 있는 대표적 대형 제약사
- NovartisCustomer
중추신경계·희귀질환 영역에서 파이프라인 기술이전 가능성이 있는 글로벌 빅파마
- AbbVieCustomer
신경퇴행성질환 및 면역·희귀질환 파이프라인 협업 가능성이 있는 대형 제약사
About Gain Therapeutics
- What technical signals does Gain Therapeutics (GANX) have?
- Gain Therapeutics current technical signals: no active technical signal.
- Is Gain Therapeutics a cup-and-handle pattern?
- No. Gain Therapeutics has no valid Cup signal right now.
- What published figures are available for Gain Therapeutics?
- Market cap: $65.77M. Trailing 12 months PER: -3.6×. Latest quarter PBR: 6.49×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Gain Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).